Kistler-Tiffany Companies’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,019
Closed -$399K 608
2019
Q3
$399K Sell
4,019
-3,223
-45% -$306K 0.15% 86
2019
Q2
$669K Sell
7,242
-1,746
-19% -$166K 0.25% 60
2019
Q1
$848K Sell
8,988
-150
-2% -$13.1K 0.35% 48
2018
Q4
$586K Buy
9,138
+686
+8% +$50.6K 0.27% 59
2018
Q3
$756K Buy
8,452
+195
+2% +$17.2K 0.31% 55
2018
Q2
$656K Sell
8,257
-84
-1% -$6.97K 0.29% 62
2018
Q1
$744K Buy
8,341
+700
+9% +$67.2K 0.31% 59
2017
Q4
$797K Buy
7,641
+937
+14% +$106K 0.31% 60
2017
Q3
$978K Hold
6,704
0.41% 46
2017
Q2
$871K Buy
6,704
+125
+2% +$15.3K 0.4% 45
2017
Q1
$819K Buy
6,579
+260
+4% +$31.1K 0.39% 47
2016
Q4
$731K Sell
6,319
-145
-2% -$16.1K 0.36% 51
2016
Q3
$676K Buy
6,464
+444
+7% +$48.1K 0.33% 53
2016
Q2
$594K Buy
6,020
+255
+4% +$26.4K 0.3% 55
2016
Q1
$577K Buy
5,765
+70
+1% +$7.21K 0.32% 55
2015
Q4
$682K Buy
5,695
+500
+10% +$57.8K 0.38% 49
2015
Q3
$562K Sell
5,195
-10
-0.2% -$1.24K 0.34% 54
2015
Q2
$602K Buy
5,205
+350
+7% +$40K 0.36% 51
2015
Q1
$560K Buy
4,855
+565
+13% +$67.5K 0.36% 53
2014
Q4
$480K Sell
4,290
-756
-15% -$79.7K 0.31% 58
2014
Q3
$478K Buy
5,046
+1,756
+53% +$158K 0.32% 58
2014
Q2
$283K Buy
3,290
+2,140
+186% +$163K 0.21% 81
2014
Q1
$80K Buy
1,150
+70
+6% +$5.54K 0.06% 181
2013
Q4
$91K Sell
1,080
-100
-8% -$7.91K 0.07% 174
2013
Q3
$91K Hold
1,180
0.07% 167
2013
Q2
$69K Buy
+1,180
New +$71K 0.06% 181

Other funds holding CELG

Kistler-Tiffany Companies's CELG Position: Q4 2019 in Review

Kistler-Tiffany Companies sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,019 shares — an estimated $399K sold.

Kistler-Tiffany Companies first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $978K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Kistler-Tiffany Companies reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 4,019 Celgene Corp shares in Q4 2019, an estimated $399K.
  • Kistler-Tiffany Companies first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Kistler-Tiffany Companies's Celgene Corp position peaked at $978K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Kistler-Tiffany Companies's 13F filing for Q4 2019, filed 14 Jan 2020.